Alterola Biotech Inc 's ROA from the second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Alterola Biotech Inc 's ROA in the second quarter of 2025?
Alterola Biotech Inc recorded a cumulative net loss of $-3 million during 12 months ending in the second quarter of 2025, resulting in a negative return on assets (ROA) of -490.75%.

However, within the Consumer Non Cyclical sector 195 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2024 quarter, so far to 5012, from total ROA ranking in the first quarter of 2025 at 5094.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2024) II. Quarter	(Jun 30 2024) I. Quarter	(Mar 31 2024) IV. Quarter	(Dec 31 2023) III. Quarter	(Sep 30 2023) II. Quarter
Y / Y Total Assets Change	174.35 %	-92.03 %	-99.97 %	-99.97 %	-95.92 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-3	-2	-2	-3	-1
Return On Assets (TTM)	-490.75 %	-624.52 %	-74.57 %	-46.01 %	-15.03 %
ALTA's Total Ranking	# 5012	# 5094	# 4553	# 5070	# 3896
Total Assets (TTM) in million	1	1	0	0	0
Seq. Total Assets Change	39.87 %	26524.35 %	2.06 %	-99.28 %	-95.93 %
Seq. Net Income Change	-	-	-	-	-

ALTA's 5 Years Annual ROA >> Back to ALTA Management Effectiveness >> Compare ALTA ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 27
Sector	# 196
Overall	# 4910

Return On Assets Statistics
High	Average	Low
1.04 %	-508.8 %	-1877.88 %
(Mar 31 2021)		(Dec 31 2020)

Financial Statements
Alterola Biotech Inc 's Assets	$ 1 million	ALTA's Balance sheet
Alterola Biotech Inc 's Income	$ -1 million	Quarterly ALTA's Income Statement
ALTA's Income by Division		See ALTA's Income by Division

Annual Return On Assets	(Mar 31 2024) FY 2024	(Mar 31 2023) FY 2023	(Mar 31 2022) FY 2022	(Mar 31 2021) FY 2021	(Sep 30 2020) FY 2020
Y / Y Total Assets Change	-99.97 %	0.9 %	2426.65 %	-99.98 %	21086146.07 %
Total Assets in million	0	12	12	0	3,098
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-2	-2	-6	0	0
Annual Return On Assets	-64820.61 %	-14.24 %	-53.36 %	-64.48 %	-0.01 %

ALTA's 5 Years Annual ROA >> Back to ALTA Management Effectiveness >> Compare ALTA ROA to its Competitors

More Return On Assets Ratios
ALTA's' Return on Assets at Yahoo Finance
Legal Cannabis Industry Return On Assets Trends and Statistics
Consumer Non Cyclical Sector Roa Statistics
Roa Trends for overall market
ALTA's Roa Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ALTA's Competitors
Subscribers only: Roa for Alterola Biotech Inc 's Suppliers
Subscribers only: Return On Assets for ALTA's Customers

You may also want to know
ALTA's Roi	ALTA's Inventory Turnover Ratio	ALTA's Growth Rates	ALTA's Dividend Comparisons
	ALTA's Profitability Ratios	ALTA's Asset Turnover Ratio	ALTA's Dividend Growth
ALTA's Roe	ALTA's Valuation Ratios	ALTA's Financial Strength Ratios	ALTA's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2024, within Consumer Non Cyclical Sector

ROA

Date modified: 2026-09-08T15:11:23+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.